• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Lipid mediator impairs macrophage immunity against tuberculosis

by
November 8, 2026
in Biology
Reading Time: 3 mins read
0
Lipid mediator impairs macrophage immunity against tuberculosis

Lipid mediator impairs macrophage immunity against tuberculosis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have identified a specific lipid mediator, Resolvin D5, that reprograms the metabolic activity of human macrophages, thereby compromising their ability to control Mycobacterium tuberculosis. This finding, published in Cellular and Molecular Life Sciences, offers a new perspective on how the bacterium evades innate immunity. The study focuses on the immunometabolic window provided by tuberculous pleural effusion, a common extrapulmonary manifestation of tuberculosis that frequently coexists with pulmonary disease. By analyzing patient-derived samples, the team demonstrated that the microenvironment of the pleural effusion induces a distinct metabolic state in macrophages that directly undermines their antimicrobial functions.

The investigation began with the observation that Mycobacterium tuberculosis has evolved sophisticated strategies to establish persistent infection by evading the host’s innate immune defenses. Despite this knowledge, the precise mechanisms by which the bacterium reprograms human macrophage metabolism remained incompletely defined. The researchers utilized tuberculous pleural effusion samples because this condition offers a clinically relevant and unique environment for studying the interaction between the pathogen and the host immune system. The study design involved a detailed lipidomic analysis of these samples to identify specific molecular changes associated with immune dysfunction.

Lipidomic analysis of the patient-derived samples revealed a significant enrichment of Resolvin D5, a specialized pro-resolving mediator. The abundance of this lipid was strongly associated with reduced glycolytic activity in the macrophages. The reduction in this activity suggests that the presence of Resolvin D5 shifts the metabolic profile of macrophages away from a state of high antimicrobial capacity. This metabolic shift appears to be a key factor in the compromised immune response observed in the pleural microenvironment.

To determine whether Resolvin D5 was actively produced in response to the infection, the researchers examined the acellular fraction of the tuberculous pleural effusion. They found that this fraction promoted the production of Resolvin D5 by monocytes. This observation was consistent with increased expression of the biosynthetic enzymes required for Resolvin D5 synthesis in pleural monocytes isolated from tuberculosis patients.

Further experiments confirmed the functional impact of Resolvin D5 on macrophage behavior. Exogenous treatment of macrophages with Resolvin D5 was sufficient to reduce glycolysis and impair the intracellular control of Mycobacterium tuberculosis. This demonstrates that the lipid mediator is not merely correlated with immune dysfunction but is capable of directly causing it. The results highlight a causal link between the accumulation of Resolvin D5 and the failure of macrophages to eliminate the bacterium.

The study also investigated the signaling pathways involved in this metabolic reprogramming. Pharmacological blockade of the GPR32 receptor counteracted the effects of Resolvin D5, supporting the involvement of GPR32 signaling in the macrophage response. Pharmacological stabilization of HIF-1α restored several macrophage functions that had been impaired by Resolvin D5, further linking the lipid mediator to specific intracellular signaling pathways.

These findings identify Resolvin D5 as a biologically relevant lipid mediator that reproduces key features of the macrophage dysfunction induced by the tuberculous pleural effusion microenvironment. The study supports a role for GPR32- and HIF-1α-associated pathways in this process, providing a mechanistic framework for understanding how the pathogen manipulates host metabolism. The research underscores the complexity of the immune response to tuberculosis and highlights the importance of metabolic reprogramming in the establishment of persistent infection.

Subject of Research: Lipid-mediated reprogramming of macrophage metabolism in tuberculosis

Article Title: Lipid-mediated GPR32 signaling reprograms macrophage metabolism to impair anti-tuberculous immunity

Article References: Barros, J., Ferrini, L., Maio, M., Ledesma, M. M., Boix, M. E., Faivre, N., Monard, S. C., Marín Franco, J. L., Métais, A., Sabbione, F., Fuentes, F., Grosso, T. M., Rengel, D., Errea, A. J., Aragone, X., Sanchez Cunto, M., Palmero, D., Matteo, M., Ostrowski, M., … Balboa, L. (2026). Lipid-mediated GPR32 signaling reprograms macrophage metabolism to impair anti-tuberculous immunity. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06480-y

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06480-y

Keywords: tuberculosis, macrophages, Resolvin D5, GPR32, metabolism, innate immunity, pleural effusion, Mycobacterium tuberculosis, glycolysis, HIF-1α, Lipid-mediated, signaling

News Source: Kristina Jarvis. (November 8, 2026). Lipid mediator impairs macrophage immunity against tuberculosis. Scienmag.

Tags: glycolysisGPR32HIF-1αInnate immunityLipid-mediatedmacrophagesmetabolismMycobacterium tuberculosispleural effusionResolvin D5signalingTuberculosis
Share12Tweet7Share2ShareShareShare1

Related Posts

Retrospective Study Tracks Seasonal Reproductive Output in Golden Lizard Canaries

Retrospective Study Tracks Seasonal Reproductive Output in Golden Lizard Canaries

November 17, 2026
Closing the Trustworthiness Gap in Multimodal Cardiovascular AI Systems

Closing the Trustworthiness Gap in Multimodal Cardiovascular AI Systems

November 17, 2026

Extracellular Vesicles Offer Diagnostic and Therapeutic Opportunities in Sjogren’s Syndrome

November 17, 2026

Agricultural Soil Microbiome Research Requires Multi-Omics Framework to Establish Ecological Causation

November 17, 2026

POPULAR NEWS

  • Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

    Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

    29 shares
    Share 12 Tweet 7
  • Microglia Study Identifies FKBP5 as a Regulator of Alzheimer’s Inflammation

    29 shares
    Share 12 Tweet 7
  • Holmium Substitution Improves SmFeO3 Supercapacitor Electrochemical Performance in KI/KOH Electrolyte

    29 shares
    Share 12 Tweet 7
  • Comorbidities Associated With Lower RSV Humoral and Cellular Immunity in Older Adults

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Far-red light deficiency reduces growth uniformity in dense sunflower seedlings

Retrospective Study Tracks Seasonal Reproductive Output in Golden Lizard Canaries

Elevated Seminal Malondialdehyde Linked to Infertility in Nigerian Men

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.